Some providers featured on this site may compensate us. This may affect the order and placement of listings but does not influence our editorial ratings or reviews.
TopWeightLoss.ioTreatments Hub
Comparison6 min read

HealthRx Alternatives 2026: Escaping the $1,188 Prepay

Six HealthRx alternatives if you won't prepay $1,188 for a year of GLP-1 treatment - from embody's $69 flat with no commitment to Medvi's 14,000-review program.

Updated September 15, 2026

Francheska Capistrano, Medical Content Reviewer

Reviewed for medical accuracy by Francheska Capistrano, RMT, MPH

Reviewed · How we review

Key takeaways

  • Shoppers leave HealthRx for three reasons: $1,188 at checkout is too much cash at once, the newer brand lacks a track record, or tirzepatide from $179 is beatable.
  • Prepay-averse: embody is $69/month flat with cancel-anytime terms and a refund if not approved ($828 for a committed year vs $1,188); altRx ($89, pause anytime) adds Buy Now, Pay Later.
  • Track record: wellmedr pairs $49/month with over one million patients and a weight-loss warranty; Medvi ($99 promo) brings 4.3 on Trustpilot across 14,836 reviews plus video visits and a dietician.
  • Tirzepatide: wellmedr $89, embody $119, DirectMeds $147 flat and Medvi $166 promo all beat HealthRx's $179 - annual gaps of $156-$960.

Why people balk - and what each objection points to

HealthRx's program itself audits well (LegitScript-certified, clinician-gated, overnight cold-chain - the case is in our legitimacy investigation). When shoppers walk away, it's for one of three reasons: the $1,188 at checkout is too much cash at once, the newer brand hasn't earned a year of trust yet, or tirzepatide from $179 is beatable. Each objection has a precise best answer - not a generic list.

Our top-rated GLP-1 providers

Our recommended telehealth providers - the same cards from our full comparison.

Our Most Popular
1
embody logo

Exceptional

9.8out of 10

Limited Offer - GLP-1 for $69/mon

Money-back guaranteeFree expedited delivery

Treatments offered

Compounded semaglutide injections (GLP-1) · Compounded tirzepatide injections (GLP-1 + GIP) · 100% online doctor review and prescription · Dosage adjustments through the patient portal

Starting price

$79$69/month

*Compounded medications are not FDA-approved.

  • Compounded semaglutide ($69/mo) and tirzepatide ($119/mo)
  • 5-minute health qualifier; doctor review usually within 24 hrs
  • Free 1-2 day shipping - temperature-controlled, tracked, insured
  • No insurance required, no clinic visits, cancel anytime

from $69/month

Visit SiteRead full review
3.8Trustpilot(8,398)

embody offers doctor-prescribed GLP-1 weight loss treatment - compounded semaglutide and tirzepatide injections - through a 100% online process. Getting started takes a roughly 5-minute health qualifier, after which a medical practitioner reviews your chart (embody says usually within 24 hours, often under 5). Pricing is flat and simple: $69/month for semaglutide and $119/month for tirzepatide, with no insurance required, no hidden fees, and no clinic visits. Medication ships in 1-2 days in temperature-controlled, tracked, insured packaging, and embody is LegitScript-certified and works with US-based 503A compounding pharmacies. On Trustpilot, embody averages 3.8 across 8,398 reviews - an honest, mixed-to-positive record whose recent reviews cluster around two themes: responsive, proactive customer service ('from my very first inquiry I've had excellent communication... customer service updated me every step,' writes one tirzepatide patient) and the no-surprises pricing ('Love the fact that there are no surprises as in costly up front cost'). A 3.7 also means a minority of customers had negative experiences - worth reading both ends of the reviews before deciding, as with any provider.

Read full embody review
2
altRx logo

Exceptional

9.7out of 10

Most Comprehensive GLP-1 Medication Access

Transparent pricingNo insurance required

Treatments offered

Compounded semaglutide (GLP-1) injection · Compounded tirzepatide (GLP-1 + GIP) injection · Brand-name Zepbound and Wegovy · One simple injection per week

Starting price

$199$89/month

*Compounded medications are not FDA-approved.

  • Compounded GLP-1 from $89/mo, GLP-1 + GIP from $149/mo
  • Brand-name options too: Zepbound and Wegovy
  • Clinician-guided - physician, PA, or nurse practitioner
  • Free shipping (about 5-7 days)

from $89/month

altRx bills itself as "the #1 most affordable GLP-1 program," and its published prices largely back that up: compounded GLP-1 (semaglutide) from $89/month and GLP-1 + GIP (tirzepatide) from $149/month - flat at every dose, so the price doesn't climb as you titrate up - alongside one of the few genuine brand-name shelves in this space (Ozempic $1,149, Zepbound $1,249, Wegovy $1,579 per month). It's a self-pay telehealth service: you complete a short assessment, a licensed provider (physician, PA, or nurse practitioner) reviews it, and if appropriate a prescription goes to a licensed US pharmacy, with free shipping in about 5-7 days. No insurance is required, Buy Now, Pay Later is available, and you can pause or cancel anytime. Two things to know before the details: shipping is slower than the 1-2 day providers (embody, DirectMeds), and Trustpilot does not currently display an aggregate score on altRx's profile - the individual reviews we quote on this page are real, but there's no independent average to lean on the way there is for rivals like Medvi (4.3 across 14,836) or embody (3.8 across 8,398). One of the real 4-star reviews we surface notes a refill 'yet to be fulfilled with zero reason as to why' - worth factoring in alongside the price advantage.

Read full altRx review
3
trimrx logo

Excellent

9.4out of 10

Limited time offer - $140 off all weight loss plans

HIPAA compliantMade in USA

Treatments offered

Compounded semaglutide (GLP-1) injection · Compounded tirzepatide (GLP-1 + GIP) injection · Custom dosing schedules set by your provider · Unlimited check-ins throughout treatment

Starting price

$289$149/month

*Compounded medications are not FDA-approved.

  • Compounded semaglutide $149/month - same price at every dose
  • Compounded tirzepatide $259/month
  • Custom dosing with unlimited provider check-ins
  • Free consultation and free tracked delivery - often next-day

from $149/month

Visit SiteRead full review
3.7Trustpilot(5,670)

trimrx is a telehealth GLP-1 program built around custom dosing: compounded semaglutide at $149/month (a $140 discount applied, the same price at every dose) and compounded tirzepatide at $259/month, with the consultation, tracked delivery, and unlimited provider check-ins all included in the price. The flow is the standard cash-pay one - a free 2-minute assessment, review by a qualified doctor (with a telehealth call if more information is needed), then free tracked shipping that often arrives as soon as the next day. On Trustpilot, trimrx averages 3.7 across 5,670 reviews - a genuinely mixed record. The positive end is vivid: 'I have lost 41 lbs... My high blood pressure is gone,' writes one tirzepatide patient, and another praises a rep who was 'very kind and helpful' even as the reviewer ultimately chose their own doctor. But a 3.6 means a meaningful minority report problems, and it's the weakest published average among the affiliate providers in our ranking. Read both ends of its recent reviews before signing up - and weigh the price against the $49-$89 entry tier at wellmedr, embody and altRx.

Read full trimrx review

Objection: "I won't prepay a year" → embody, then altRx

embody is the anti-prepay: $69/month flat, cancel anytime, and your total exposure on month one is $69 - not $1,188. It keeps most of what makes HealthRx attractive (LegitScript certification, 503A pharmacies, fast free shipping at 1-2 days vs overnight) and adds a full refund if a provider doesn't approve you. Over a committed year it's also cheaper: $828 vs $1,188. altRx ($89/month, pause anytime) is the runner-up with a twist - Buy Now, Pay Later, which is precisely the financial instrument the prepay-averse are asking for.

Shop GLP-1 plans by product

Every provider's published plans - cheapest first, conditions under each price.

Objection: "newer brand, no track record" → wellmedr or Medvi

Track record shopping has two ends. wellmedr pairs budget pricing ($49/month, 12-month lock billed monthly - commitment without the lump sum) with scale: over one million patients and a weight-loss warranty. Medvi (currently $99/month promotional, all-inclusive) brings the receipts money can't fake: 4.3 on Trustpilot across 14,836 reviews, video visits, and a dietician on every plan. Both let a skeptic buy proof instead of promises - we ran the direct matchup in HealthRx vs Medvi.

Objection: "tirzepatide pricing" → three cheaper doors

HealthRx's tirzepatide starts at $179; four providers beat it outright: wellmedr at $89, embody at $119, DirectMeds at a flat $147 - the market's only needle-free sublingual option - and Medvi at $166 promotional. Annual gaps run $156-$960.

AlternativeSemaglutideUpfront exposureBeats HealthRx on
embody$69/mo$69No commitment, refund policy, year-total
wellmedr$49/moOne monthPrice + million-patient scale
altRx$89/moOne month (BNPL)Flexibility + brand-name shelf
DirectMeds$147/moOne monthTirzepatide price, drops format
Medvi$99/mo promoOne monthSupport + 14k-review record
SHED$199/moOne monthCoaching + money-back guarantee

And the counter-case for staying: if the year is genuinely decided and overnight delivery matters to you, none of the objections apply - HealthRx's $99 committed rate with the best logistics in the ranking is exactly what it claims to be.

→ Sixty seconds to a personalized answer: take the matching quiz

This article is general information, not medical advice. Prices as listed at the time of writing.

Ready to compare weight loss providers?

See how top providers stack up on pricing, medical support, and treatment options.

Compare providers head-to-head

Real prices, real trade-offs - the comparisons readers use to decide.

Sources & medical references

Treatment facts on this page are grounded in regulatory guidance and peer-reviewed research. Pricing and plan details come from each provider's published information. This content is for information only and is not medical advice - always consult a licensed clinician before starting treatment.

  1. 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
  2. 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
  3. 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
  4. 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
  5. 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
  6. 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
  7. 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)